Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02307058 · ClinicalTrials.gov registry record · NA

Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy

A NA study of Prostate Cancer, sponsored by University of Miami.

Active
Registry status
NA
Development phase
164
Enrollment target
1
Study location

NCT02307058 is a NA study of Prostate Cancer that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 164 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02307058, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
164 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to learn about: 1) improving control of prostate cancer using an extra high dose radiation treatment to the MRI defined high risk tumor areas, in addition to the standard radiation treatment to the rest of the prostate; 2) preserving quality of life by reducing dose to the nearby organs at risk around the prostate; and 3) establishing the relationship of pre- and post-treatment MRI to MRI-directed biopsy results at 2-2.5 years after treatment.

Conditions Studied

Prostate Cancer

Interventions

  • RADIATION LEAD RT
  • RADIATION HEIGHT RT

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2015-02-05
Est. Completion 2031-07-31
Phase NA

Sponsor

University of Miami

721 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02307058

The ClinicalTrials.gov registry entry for NCT02307058 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (73% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which LEAD RT is the first listed.

NCT02307058 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02307058 about?

NCT02307058 is a clinical study titled "Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy". The purpose of this research study is to learn about: 1) improving control of prostate cancer using an extra high dose radiation treatment to the MRI defined high risk tumor areas, in addition to the standard radiation treatment to the rest of the prostate; 2) preserving quality of life by reducing ...

What is the current status of trial NCT02307058?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 164 participants. The study started on 2015-02-05. Estimated completion is 2031-07-31.

What conditions does trial NCT02307058 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT02307058?

The interventions under investigation include: LEAD RT (RADIATION), HEIGHT RT (RADIATION).

Who is sponsoring clinical trial NCT02307058?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02307058 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.